Israeli Stocks To Buy Based on Machine Learning: Returns up to 93.63% in 3 Months

Israeli Stocks To Buy

This forecast is part of the By Country – Israeli Stocks To Buy Package, as one of I Know First’s algorithmic trading tools. The full Israeli stocks forecast includes daily predictions for a total of 20 stocks with bullish and bearish signals:

  • Top 10 Israeli stocks for the long position
  • Top 10 Israeli stocks for the short position

Israeli Stocks
Package Name: By Country – Israeli Stocks
Recommended Positions: Long
Forecast Length: 3 Months (2/19/2020 – 5/19/2020)
I Know First Average: 20.38%
Israeli Stocks To Buy
Israeli Stocks To Buy chart

During the 3 Months forecasted period several picks in the By Country – Israeli Stocks Package saw significant returns. The algorithm had correctly predicted 6 out 10 returns. PSTI was the highest-earning trade with a return of 93.63% in 3 Months. SPCB and CGEN also performed well for this time horizon with returns of 80.64% and 42.08%, respectively. The package had an overall average return of 20.38%, providing investors with a 33.65% premium over the TASE index return of -13.27% during the period.

Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company’s lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. The Company’s operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company’s products include PLX-PAD and PLX R18. The Company’s PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company’s PLX products are administered using a standard needle and syringe. The Company’s PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women’s health diseases.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.